Concepts (212)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Radiology | 12 | 2022 | 1931 | 2.040 |
Why?
|
Students, Medical | 4 | 2022 | 1740 | 1.200 |
Why?
|
Peripheral Arterial Disease | 3 | 2022 | 1206 | 0.960 |
Why?
|
Artificial Intelligence | 7 | 2022 | 1661 | 0.850 |
Why?
|
Radiology, Interventional | 5 | 2022 | 417 | 0.840 |
Why?
|
Appointments and Schedules | 3 | 2021 | 427 | 0.790 |
Why?
|
Biomedical Research | 5 | 2022 | 3266 | 0.760 |
Why?
|
Cryosurgery | 2 | 2022 | 408 | 0.680 |
Why?
|
Adrenal Gland Neoplasms | 2 | 2019 | 731 | 0.610 |
Why?
|
Ablation Techniques | 1 | 2019 | 230 | 0.610 |
Why?
|
Radiology Department, Hospital | 4 | 2021 | 413 | 0.600 |
Why?
|
Point-of-Care Systems | 2 | 2022 | 1104 | 0.590 |
Why?
|
Research Personnel | 2 | 2017 | 513 | 0.500 |
Why?
|
Body Water | 1 | 2015 | 352 | 0.500 |
Why?
|
Career Choice | 5 | 2021 | 743 | 0.500 |
Why?
|
Internship and Residency | 3 | 2022 | 5556 | 0.490 |
Why?
|
Mammography | 3 | 2015 | 2442 | 0.470 |
Why?
|
Adipose Tissue | 2 | 2015 | 3234 | 0.460 |
Why?
|
Rectal Neoplasms | 1 | 2021 | 1117 | 0.450 |
Why?
|
Subtraction Technique | 1 | 2015 | 543 | 0.430 |
Why?
|
Magnetic Resonance Imaging | 12 | 2021 | 34151 | 0.400 |
Why?
|
Physicians | 3 | 2022 | 4292 | 0.370 |
Why?
|
Glutamine | 1 | 2012 | 567 | 0.360 |
Why?
|
Hormones | 1 | 2013 | 855 | 0.360 |
Why?
|
Colonic Neoplasms | 1 | 2021 | 2535 | 0.350 |
Why?
|
Patient Readmission | 1 | 2022 | 2952 | 0.350 |
Why?
|
Endovascular Procedures | 1 | 2022 | 1959 | 0.350 |
Why?
|
Pandemics | 5 | 2022 | 7089 | 0.310 |
Why?
|
Image Interpretation, Computer-Assisted | 4 | 2015 | 3418 | 0.310 |
Why?
|
Absorptiometry, Photon | 1 | 2013 | 1692 | 0.310 |
Why?
|
Breast Neoplasms | 10 | 2017 | 19800 | 0.310 |
Why?
|
Mentors | 2 | 2022 | 604 | 0.300 |
Why?
|
Breast | 2 | 2015 | 1782 | 0.300 |
Why?
|
Atherosclerosis | 1 | 2022 | 3228 | 0.300 |
Why?
|
Liver Neoplasms | 1 | 2022 | 4044 | 0.300 |
Why?
|
Menopause | 1 | 2013 | 1518 | 0.280 |
Why?
|
Mammaplasty | 1 | 2014 | 1126 | 0.270 |
Why?
|
Referral and Consultation | 3 | 2022 | 3436 | 0.260 |
Why?
|
Radiography | 4 | 2022 | 6989 | 0.250 |
Why?
|
Patient Acceptance of Health Care | 1 | 2018 | 2927 | 0.250 |
Why?
|
Humans | 54 | 2022 | 708843 | 0.250 |
Why?
|
Faculty | 2 | 2022 | 344 | 0.230 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2012 | 3006 | 0.210 |
Why?
|
Tomography, X-Ray Computed | 3 | 2019 | 20308 | 0.210 |
Why?
|
Dissent and Disputes | 1 | 2022 | 145 | 0.210 |
Why?
|
Patient-Centered Care | 2 | 2022 | 1446 | 0.200 |
Why?
|
Female | 29 | 2022 | 375205 | 0.200 |
Why?
|
Limb Salvage | 1 | 2022 | 446 | 0.190 |
Why?
|
Retrospective Studies | 12 | 2022 | 71483 | 0.190 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2022 | 761 | 0.170 |
Why?
|
Awards and Prizes | 1 | 2022 | 345 | 0.170 |
Why?
|
Male | 17 | 2022 | 349524 | 0.160 |
Why?
|
Lower Extremity | 2 | 2022 | 1041 | 0.160 |
Why?
|
Education, Graduate | 1 | 2017 | 72 | 0.160 |
Why?
|
Amputation | 1 | 2022 | 791 | 0.150 |
Why?
|
Practice Management, Medical | 1 | 2018 | 204 | 0.150 |
Why?
|
Adnexal Diseases | 1 | 2017 | 104 | 0.150 |
Why?
|
Middle Aged | 16 | 2022 | 213752 | 0.150 |
Why?
|
Mechanics | 1 | 2005 | 15 | 0.150 |
Why?
|
Quality of Health Care | 2 | 2022 | 4266 | 0.140 |
Why?
|
ROC Curve | 3 | 2019 | 3518 | 0.140 |
Why?
|
Leadership | 2 | 2021 | 1325 | 0.140 |
Why?
|
Salicylates | 1 | 2005 | 129 | 0.140 |
Why?
|
Primary Health Care | 2 | 2022 | 4485 | 0.130 |
Why?
|
Fat Necrosis | 1 | 2014 | 61 | 0.130 |
Why?
|
Hair Cells, Auditory, Outer | 1 | 2005 | 91 | 0.130 |
Why?
|
Aged | 12 | 2022 | 161488 | 0.130 |
Why?
|
Mammary Glands, Human | 1 | 2015 | 206 | 0.130 |
Why?
|
Pilot Projects | 2 | 2019 | 7994 | 0.120 |
Why?
|
United States | 12 | 2022 | 67165 | 0.120 |
Why?
|
Infection Control | 1 | 2021 | 959 | 0.120 |
Why?
|
Wavelet Analysis | 1 | 2013 | 63 | 0.120 |
Why?
|
Cyclooxygenase Inhibitors | 1 | 2005 | 388 | 0.120 |
Why?
|
Cross-Sectional Studies | 3 | 2022 | 23020 | 0.120 |
Why?
|
Burnout, Professional | 1 | 2021 | 628 | 0.120 |
Why?
|
Risk Factors | 6 | 2022 | 69553 | 0.110 |
Why?
|
Breast Feeding | 1 | 2020 | 1273 | 0.110 |
Why?
|
Incidental Findings | 1 | 2017 | 668 | 0.110 |
Why?
|
Patients | 1 | 2018 | 738 | 0.110 |
Why?
|
Pennsylvania | 1 | 2013 | 651 | 0.110 |
Why?
|
Feasibility Studies | 1 | 2021 | 4883 | 0.110 |
Why?
|
Low Back Pain | 1 | 2019 | 922 | 0.100 |
Why?
|
Kaplan-Meier Estimate | 1 | 2022 | 6765 | 0.100 |
Why?
|
Socioeconomic Factors | 3 | 2021 | 7644 | 0.100 |
Why?
|
Treatment Outcome | 3 | 2022 | 61932 | 0.100 |
Why?
|
Time Factors | 4 | 2022 | 41038 | 0.100 |
Why?
|
Neoplasms | 3 | 2021 | 20172 | 0.090 |
Why?
|
Patient Discharge | 1 | 2022 | 2980 | 0.090 |
Why?
|
Transplantation, Autologous | 1 | 2014 | 2092 | 0.090 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 2017 | 1086 | 0.090 |
Why?
|
Mastectomy, Segmental | 1 | 2014 | 922 | 0.090 |
Why?
|
Medical Oncology | 1 | 2021 | 2098 | 0.090 |
Why?
|
Photometry | 1 | 2008 | 53 | 0.090 |
Why?
|
Uterine Neoplasms | 1 | 2017 | 1473 | 0.080 |
Why?
|
Risk Assessment | 2 | 2022 | 23284 | 0.080 |
Why?
|
Adult | 10 | 2022 | 211041 | 0.080 |
Why?
|
Patient Compliance | 1 | 2017 | 2758 | 0.070 |
Why?
|
Fiber Optic Technology | 1 | 2008 | 290 | 0.070 |
Why?
|
Oxidation-Reduction | 1 | 2012 | 2325 | 0.070 |
Why?
|
Survival Analysis | 1 | 2019 | 10507 | 0.070 |
Why?
|
Quality Improvement | 1 | 2021 | 3733 | 0.070 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2014 | 8877 | 0.070 |
Why?
|
Spectrometry, Fluorescence | 1 | 2008 | 725 | 0.070 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2015 | 8968 | 0.070 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2017 | 2641 | 0.070 |
Why?
|
Disease Progression | 2 | 2019 | 13298 | 0.070 |
Why?
|
Mouth Mucosa | 1 | 2008 | 431 | 0.070 |
Why?
|
Internet | 1 | 2018 | 3074 | 0.070 |
Why?
|
Cell Membrane | 1 | 2005 | 3892 | 0.070 |
Why?
|
Algorithms | 3 | 2022 | 13647 | 0.070 |
Why?
|
Education, Medical, Graduate | 1 | 2017 | 2176 | 0.070 |
Why?
|
Catheter Ablation | 1 | 2017 | 2506 | 0.070 |
Why?
|
Proportional Hazards Models | 1 | 2019 | 12292 | 0.070 |
Why?
|
Demography | 2 | 2021 | 1596 | 0.070 |
Why?
|
Contrast Media | 2 | 2015 | 5267 | 0.070 |
Why?
|
Health Personnel | 1 | 2018 | 2983 | 0.070 |
Why?
|
Aged, 80 and over | 3 | 2022 | 58184 | 0.060 |
Why?
|
Survivors | 1 | 2014 | 2149 | 0.060 |
Why?
|
Health Services Accessibility | 1 | 2021 | 4988 | 0.060 |
Why?
|
Education, Medical | 1 | 2015 | 1683 | 0.060 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2013 | 3700 | 0.060 |
Why?
|
Mouth Neoplasms | 1 | 2008 | 564 | 0.060 |
Why?
|
Diagnosis, Differential | 2 | 2017 | 13274 | 0.060 |
Why?
|
Neoplasm Staging | 1 | 2017 | 11126 | 0.060 |
Why?
|
Medicare | 1 | 2019 | 5691 | 0.060 |
Why?
|
Cohort Studies | 2 | 2021 | 39292 | 0.050 |
Why?
|
Prognosis | 2 | 2019 | 28919 | 0.050 |
Why?
|
Gene Expression Profiling | 2 | 2014 | 9556 | 0.050 |
Why?
|
Energy Metabolism | 1 | 2012 | 2968 | 0.050 |
Why?
|
Career Mobility | 1 | 2022 | 263 | 0.050 |
Why?
|
Kinetics | 3 | 2013 | 6796 | 0.050 |
Why?
|
Glucose | 1 | 2012 | 4261 | 0.050 |
Why?
|
Planning Techniques | 1 | 2018 | 66 | 0.040 |
Why?
|
Proto-Oncogene Proteins | 1 | 2012 | 4677 | 0.040 |
Why?
|
Models, Biological | 2 | 2013 | 9907 | 0.040 |
Why?
|
Lactation | 1 | 2020 | 397 | 0.040 |
Why?
|
Academic Medical Centers | 2 | 2021 | 2779 | 0.040 |
Why?
|
Markov Chains | 2 | 2012 | 991 | 0.040 |
Why?
|
Adnexa Uteri | 1 | 2017 | 48 | 0.040 |
Why?
|
Area Under Curve | 2 | 2012 | 1688 | 0.040 |
Why?
|
Training Support | 1 | 2017 | 121 | 0.040 |
Why?
|
Image Enhancement | 1 | 2008 | 2975 | 0.040 |
Why?
|
Microwaves | 1 | 2017 | 173 | 0.040 |
Why?
|
Multicenter Studies as Topic | 1 | 2021 | 1513 | 0.040 |
Why?
|
Radio Waves | 1 | 2017 | 248 | 0.040 |
Why?
|
Prevalence | 1 | 2013 | 14712 | 0.040 |
Why?
|
Social Responsibility | 1 | 2018 | 381 | 0.040 |
Why?
|
Cell Proliferation | 1 | 2012 | 10803 | 0.040 |
Why?
|
Task Performance and Analysis | 1 | 2019 | 812 | 0.030 |
Why?
|
Workplace | 1 | 2020 | 852 | 0.030 |
Why?
|
Lung Neoplasms | 1 | 2018 | 12183 | 0.030 |
Why?
|
Awareness | 1 | 2018 | 597 | 0.030 |
Why?
|
Guinea Pigs | 1 | 2005 | 1432 | 0.030 |
Why?
|
Minority Groups | 1 | 2020 | 1077 | 0.030 |
Why?
|
Research | 1 | 2022 | 2009 | 0.030 |
Why?
|
Consensus | 1 | 2022 | 2713 | 0.030 |
Why?
|
Vascular Surgical Procedures | 1 | 2022 | 1510 | 0.030 |
Why?
|
Early Detection of Cancer | 2 | 2018 | 2865 | 0.030 |
Why?
|
Faculty, Medical | 1 | 2021 | 1156 | 0.030 |
Why?
|
Pyruvic Acid | 1 | 2013 | 189 | 0.030 |
Why?
|
Specialization | 1 | 2017 | 791 | 0.030 |
Why?
|
Outpatients | 1 | 2019 | 1349 | 0.030 |
Why?
|
Health Services Research | 1 | 2019 | 1836 | 0.030 |
Why?
|
Social Support | 1 | 2020 | 2119 | 0.030 |
Why?
|
Gadolinium DTPA | 1 | 2014 | 827 | 0.030 |
Why?
|
Societies, Medical | 1 | 2022 | 3776 | 0.020 |
Why?
|
Stress, Mechanical | 1 | 2005 | 1714 | 0.020 |
Why?
|
Postoperative Complications | 2 | 2022 | 15053 | 0.020 |
Why?
|
Critical Care | 1 | 2022 | 2473 | 0.020 |
Why?
|
Computer Simulation | 2 | 2013 | 6048 | 0.020 |
Why?
|
Cochlea | 1 | 2005 | 782 | 0.020 |
Why?
|
Intensive Care Units | 1 | 2022 | 3418 | 0.020 |
Why?
|
Reproducibility of Results | 3 | 2013 | 19423 | 0.020 |
Why?
|
Health Promotion | 1 | 2021 | 2172 | 0.020 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2017 | 1988 | 0.020 |
Why?
|
Signal Transduction | 1 | 2012 | 23950 | 0.020 |
Why?
|
Models, Statistical | 2 | 2015 | 5034 | 0.020 |
Why?
|
Lactic Acid | 1 | 2013 | 1126 | 0.020 |
Why?
|
Optical Fibers | 1 | 2008 | 132 | 0.020 |
Why?
|
Ambulatory Care | 1 | 2019 | 2765 | 0.020 |
Why?
|
Mutation | 1 | 2012 | 29262 | 0.020 |
Why?
|
Radiopharmaceuticals | 1 | 2017 | 2708 | 0.020 |
Why?
|
Animals | 3 | 2013 | 170486 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2014 | 4941 | 0.020 |
Why?
|
Mice, Nude | 1 | 2013 | 3859 | 0.020 |
Why?
|
Lymphatic Metastasis | 1 | 2014 | 2951 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 2014 | 3693 | 0.020 |
Why?
|
Equipment Failure Analysis | 1 | 2008 | 873 | 0.020 |
Why?
|
Sensitivity and Specificity | 2 | 2013 | 14836 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2013 | 3714 | 0.020 |
Why?
|
Diagnostic Imaging | 1 | 2019 | 3495 | 0.020 |
Why?
|
Pattern Recognition, Automated | 1 | 2011 | 1019 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2019 | 13536 | 0.010 |
Why?
|
Recurrence | 1 | 2015 | 8255 | 0.010 |
Why?
|
Survival Rate | 1 | 2017 | 13202 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2005 | 11239 | 0.010 |
Why?
|
Models, Genetic | 1 | 2013 | 3539 | 0.010 |
Why?
|
Adolescent | 2 | 2021 | 84718 | 0.010 |
Why?
|
Risk | 1 | 2014 | 9641 | 0.010 |
Why?
|
Software | 1 | 2015 | 4345 | 0.010 |
Why?
|
Young Adult | 2 | 2018 | 55940 | 0.010 |
Why?
|
Logistic Models | 1 | 2015 | 13468 | 0.010 |
Why?
|
Computational Biology | 1 | 2012 | 3568 | 0.010 |
Why?
|
Pregnancy | 1 | 2020 | 26832 | 0.010 |
Why?
|
Equipment Design | 1 | 2008 | 3627 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2005 | 20170 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2015 | 21194 | 0.010 |
Why?
|
Phenotype | 1 | 2014 | 16306 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2013 | 16959 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2012 | 15252 | 0.010 |
Why?
|
Child | 1 | 2021 | 73636 | 0.010 |
Why?
|
Mice | 1 | 2013 | 80876 | 0.000 |
Why?
|
Concepts
(212)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(70)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_